默沙东 MRK 深 沪
等待开盘 09-23 09:30:00 美东时间
150.91
+1.410
+0.94%
华盛通- 最 高153.57
- 今 开148.69
- 成交量 1110.50万股
- 最 低 148.04
- 昨 收 149.50
- 总市值 3723.21亿
- 52周最高 156.0699
- 市盈率 静 20.73
- 换手率 0.45%
- 52周最低 78.61
- 委 比 60.00%
- 总股本 24.67亿
- 历史最高 156.0699
- 量 比 0.84
- 振 幅 3.70%
- 历史最低 -6.206
- 每 手 1
- 风险率 18.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多高盛首予Tempus AI“中性”评级：诊断业务等来报销红利，数据合同却进入“验证期”
高盛给予Tempus AI“中性”评级和75美元目标价;xT与xF报销红利可期，但大药企合同和护城河持久性仍待验证。
09-22 21:12
Merck says FDA approved label update for PAH therapy Winrevair
Merck (MRK) on Tuesday announced that the U.S. FDA approved a label update for Winrevair, a treatment it markets with Bristol Myers Squibb (BMY) for pulmonary arterial hypertension, acknowledging the ...
09-22 19:26
美股收盘：纳指涨超2%再创历史新高！Meta狂飙逾11%，个人AI助手Muse爆火！
纳指涨超2%再创历史新高！Meta狂飙逾11%，个人AI助手Muse爆火；CPU概念股集体大涨，英特尔涨逾12%；比特币上攻8.7万美元！Strategy涨近10%>>
09-22 07:00
Merck secures Japanese approval for subcutaneous Keytruda
Merck (MRK) has secured Japanese regulatory approval for KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph) for subcutaneous injection, covering all indications currently approved for Keytr...
09-21 20:17
Merck's Subcutaneous KEYTRUDA QLEX Approved In Japan For All Existing KEYTRUDA Indications
KEYTRUDA QLEX is the first and only subcutaneous immune checkpoint inhibitor in Japan that can be administered by a healthcare provider in as little as one minute Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the Ministry of Health, Labor and Welfare (MHLW) ...
09-21 18:47
默沙东Keytruda QLEX™（帕博利珠单抗+透明质酸酶alfa-pmph）获日本批准，可皮下注射给药，覆盖Keytruda®（帕博利珠单抗）在日本获批的所有适应症。
默沙东Keytruda QLEX™（帕博利珠单抗+透明质酸酶alfa-pmph）获日本批准，可皮下注射给药，覆盖Keytruda®（帕博利珠单抗）在日本获批的所...
09-21 18:45
太空制药！被写入“十五五”规划，新药研发已经“卷”上天
（来源：求实药社） 9月18日《医药工业发展“十五五”规划》正式发布，中国制定了雄心勃勃的目标，到2030年： 首创新药（FIC）占全球比例达到25%以上；...
09-20 12:00
HHS to launch autism research initiative utilizing AI: report
HHS is expected to unveil an autism research initiative, named SPECTRA, that will use AI to better understand the disorder and find ways to treat it earlier on. The program will evaluate data and, in ...
09-16 22:35
mRNA癌症疫苗的“热与冷”
（来源：商图药讯） 2026年8月，癌症疫苗领域迎来了一次久违的振奋。默沙东与莫德纳的个性化mRNA黑色素瘤疫苗intismeran autogene在III期...
09-16 19:30
公司简介
公司名称
|
默沙东
|
行业分类
|
制药
|
业务描述
|
默沙东公司是世界级跨国医药企业领导者，着手解决社会对医疗健康上的需要。默沙东提供创新的药物、疫苗、生物制剂及健康消费品以及动物健康产品，以改善及提升健康质素。默沙东现时已于全球140个不同地方为消费者提供医疗健康解决方案。同时藉由深入各地区角落的医疗计划，提供药品给需要的人们，以解决偏远地区医疗不足的情况。默沙东在美国及加拿大内称为默克药厂（Merck & Co., Inc.），在其他不同地区则以默沙东药厂(Merck Sharp & Dohme，MSD)为名。
|
高盛首予Tempus AI“中性”评级：诊断业务等来报销红利，数据合同却进入“验证期”
高盛给予Tempus AI“中性”评级和75美元目标价;xT与xF报销红利可期，但大药企合同和护城河持久性仍待验证。
09-22 21:12
Merck says FDA approved label update for PAH therapy Winrevair
Merck (MRK) on Tuesday announced that the U.S. FDA approved a label update for Winrevair, a treatment it markets with Bristol Myers Squibb (BMY) for pulmonary arterial hypertension, acknowledging the ...
09-22 19:26
美股收盘：纳指涨超2%再创历史新高！Meta狂飙逾11%，个人AI助手Muse爆火！
纳指涨超2%再创历史新高！Meta狂飙逾11%，个人AI助手Muse爆火；CPU概念股集体大涨，英特尔涨逾12%；比特币上攻8.7万美元！Strategy涨近10%>>
09-22 07:00
Merck secures Japanese approval for subcutaneous Keytruda
Merck (MRK) has secured Japanese regulatory approval for KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph) for subcutaneous injection, covering all indications currently approved for Keytr...
09-21 20:17
Merck's Subcutaneous KEYTRUDA QLEX Approved In Japan For All Existing KEYTRUDA Indications
KEYTRUDA QLEX is the first and only subcutaneous immune checkpoint inhibitor in Japan that can be administered by a healthcare provider in as little as one minute Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the Ministry of Health, Labor and Welfare (MHLW) ...
09-21 18:47
默沙东Keytruda QLEX™（帕博利珠单抗+透明质酸酶alfa-pmph）获日本批准，可皮下注射给药，覆盖Keytruda®（帕博利珠单抗）在日本获批的所有适应症。
默沙东Keytruda QLEX™（帕博利珠单抗+透明质酸酶alfa-pmph）获日本批准，可皮下注射给药，覆盖Keytruda®（帕博利珠单抗）在日本获批的所...
09-21 18:45
太空制药！被写入“十五五”规划，新药研发已经“卷”上天
（来源：求实药社） 9月18日《医药工业发展“十五五”规划》正式发布，中国制定了雄心勃勃的目标，到2030年： 首创新药（FIC）占全球比例达到25%以上；...
09-20 12:00
HHS to launch autism research initiative utilizing AI: report
HHS is expected to unveil an autism research initiative, named SPECTRA, that will use AI to better understand the disorder and find ways to treat it earlier on. The program will evaluate data and, in ...
09-16 22:35
mRNA癌症疫苗的“热与冷”
（来源：商图药讯） 2026年8月，癌症疫苗领域迎来了一次久违的振奋。默沙东与莫德纳的个性化mRNA黑色素瘤疫苗intismeran autogene在III期...
09-16 19:30
派息除权日
|
每股总股息
| 派息日期 |
2026-09-15
|
0.85
|
2026-10-07
|
2026-06-15
|
0.85
|
2026-07-08
|
2026-03-16
|
0.85
|
2026-04-07
|
2025-12-15
|
0.85
|
2026-01-08
|
2025-09-15
|
0.81
|
2025-10-07
|
2025-06-16
|
0.81
|
2025-07-08
|
2025-03-17
|
0.81
|
2025-04-07
|
2024-12-16
|
0.81
|
2025-01-08
|
2024-09-16
|
0.77
|
2024-10-07
|
2024-06-17
|
0.77
|
2024-07-08
|
2024-03-14
|
0.77
|
2024-04-05
|
2023-12-14
|
0.77
|
2024-01-08
|
2023-09-14
|
0.73
|
2023-10-06
|
2023-06-14
|
0.73
|
2023-07-10
|
2023-03-14
|
0.73
|
2023-04-10
|
2022-12-14
|
0.73
|
2023-01-09
|
2022-09-14
|
0.69
|
2022-10-07
|
2022-06-14
|
0.69
|
2022-07-08
|
2022-03-14
|
0.69
|
2022-04-07
|
2021-12-14
|
0.69
|
2022-01-07
|
2021-09-14
|
0.65
|
2021-10-07
|
2021-06-14
|
0.65
|
2021-07-07
|
2021-03-12
|
0.65
|
2021-04-07
|
2020-12-14
|
0.65
|
2021-01-08
|
2020-09-14
|
0.61
|
2020-10-07
|
2020-06-12
|
0.61
|
2020-07-07
|
2020-03-13
|
0.61
|
2020-04-07
|
2019-12-13
|
0.61
|
2020-01-08
|
2019-09-13
|
0.55
|
2019-10-07
|
2019-06-14
|
0.55
|
2019-07-08
|
2019-03-14
|
0.55
|
2019-04-05
|
2018-12-14
|
0.55
|
2019-01-08
|
2018-09-14
|
0.48
|
2018-10-05
|
2018-06-14
|
0.48
|
2018-07-09
|
2018-03-14
|
0.48
|
2018-04-06
|
2017-12-14
|
0.48
|
2018-01-08
|
2017-09-14
|
0.47
|
2017-10-06
|
2017-06-13
|
0.47
|
2017-07-10
|
2017-03-13
|
0.47
|
2017-04-07
|
2016-12-13
|
0.47
|
2017-01-09
|
2016-09-13
|
0.46
|
2016-10-07
|
2016-06-13
|
0.46
|
2016-07-08
|
2016-03-11
|
0.46
|
2016-04-07
|
2015-12-11
|
0.46
|
2016-01-08
|
2015-09-11
|
0.45
|
2015-10-07
|
2015-06-11
|
0.45
|
2015-07-08
|
2015-03-12
|
0.45
|
2015-04-08
|
2014-12-11
|
0.45
|
2015-01-08
|
2014-09-11
|
0.44
|
2014-10-07
|
2014-06-12
|
0.44
|
2014-07-08
|
2014-03-13
|
0.44
|
2014-04-07
|
2013-12-12
|
0.44
|
2014-01-08
|
2013-09-12
|
0.43
|
2013-10-07
|
2013-06-13
|
0.43
|
2013-07-08
|
2013-03-13
|
0.43
|
2013-04-05
|
2012-12-13
|
0.43
|
2013-01-08
|
2012-09-13
|
0.42
|
2012-10-05
|
2012-06-13
|
0.42
|
2012-07-09
|
2012-03-13
|
0.42
|
2012-04-06
|
2011-12-13
|
0.42
|
2012-01-09
|
2011-09-13
|
0.38
|
2011-10-07
|
2011-06-13
|
0.38
|
2011-07-08
|
2011-03-11
|
0.38
|
2011-04-07
|
2010-12-13
|
0.38
|
2011-01-07
|
2010-09-13
|
0.38
|
2010-10-07
|
2010-06-11
|
0.38
|
2010-07-08
|
2010-03-11
|
0.38
|
2010-04-07
|
2009-12-11
|
0.38
|
2010-01-08
|
2009-09-02
|
0.38
|
2009-10-01
|
2009-06-04
|
0.38
|
2009-07-01
|
2009-03-04
|
0.38
|
2009-04-01
|
2008-12-03
|
0.38
|
2009-01-02
|
2008-09-03
|
0.38
|
2008-10-01
|
2008-06-04
|
0.38
|
2008-07-01
|
2008-03-05
|
0.38
|
2008-04-01
|
2007-12-05
|
0.38
|
2008-01-02
|
2007-09-05
|
0.38
|
2007-10-01
|
2007-06-06
|
0.38
|
2007-07-02
|
2007-03-07
|
0.38
|
2007-04-02
|
2006-12-06
|
0.38
|
2007-01-02
|
2006-08-30
|
0.38
|
2006-10-02
|
2006-05-31
|
0.38
|
2006-07-03
|
2006-03-08
|
0.38
|
2006-04-03
|
2005-11-30
|
0.38
|
2006-01-03
|
2005-08-31
|
0.38
|
2005-10-03
|
2005-06-01
|
0.38
|
2005-07-01
|
2005-03-02
|
0.38
|
2005-04-01
|
2004-12-01
|
0.38
|
2005-01-03
|
2004-09-01
|
0.38
|
2004-10-01
|
2004-06-02
|
0.37
|
2004-07-01
|
2004-03-03
|
0.37
|
2004-04-01
|
2003-12-03
|
0.37
|
2004-01-02
|
2003-09-03
|
0.37
|
2003-10-01
|
2003-06-04
|
0.36
|
2003-07-01
|
2003-03-05
|
0.36
|
2003-04-01
|
2002-12-04
|
0.36
|
2003-01-02
|
2002-09-04
|
0.36
|
2002-10-01
|
2002-06-05
|
0.35
|
2002-07-01
|
2002-03-06
|
0.35
|
2002-04-01
|
2001-12-05
|
0.35
|
2002-01-02
|
2001-08-30
|
0.35
|
2001-10-01
|
2001-05-31
|
0.34
|
2001-07-02
|
2001-03-07
|
0.34
|
2001-04-02
|
2000-12-06
|
0.34
|
2001-01-02
|
2000-08-30
|
0.34
|
2000-10-02
|
2000-05-31
|
0.29
|
2000-07-03
|
2000-03-01
|
0.29
|
2000-04-03
|
1999-12-01
|
0.29
|
2000-01-03
|
1999-09-01
|
0.29
|
1999-10-01
|
1999-06-02
|
0.27
|
1999-07-01
|
1999-03-03
|
0.27
|
1999-04-01
|
1998-12-02
|
0.54
|
1999-01-04
|
1998-09-02
|
0.54
|
1998-10-01
|
1998-06-03
|
0.45
|
1998-07-01
|
1998-03-04
|
0.45
|
1998-04-01
|
1997-12-03
|
0.45
|
1998-01-02
|
1997-09-03
|
0.45
|
1997-10-01
|
1997-06-05
|
0.42
|
1997-07-01
|
1997-03-05
|
0.42
|
1997-04-01
|
1996-12-05
|
0.40
|
1997-01-02
|
1996-09-04
|
0.40
|
1996-10-01
|
1996-06-06
|
0.34
|
1996-07-01
|
1996-03-06
|
0.34
|
1996-04-01
|
1995-12-06
|
0.34
|
1996-01-02
|
1995-09-05
|
0.34
|
1995-10-02
|
1995-06-02
|
0.30
|
1995-07-03
|
1995-03-03
|
0.30
|
1995-04-03
|
1994-12-02
|
0.30
|
1995-01-02
|
1994-09-02
|
0.30
|
1994-10-01
|
1994-06-02
|
0.28
|
1994-07-01
|
1994-03-02
|
0.28
|
1994-04-01
|
1993-12-02
|
0.28
|
1994-01-03
|
1993-09-02
|
0.28
|
1993-10-01
|
1993-06-02
|
0.25
|
1993-07-01
|
1993-03-02
|
0.25
|
1993-04-01
|
1992-12-02
|
0.25
|
1993-01-04
|
1992-08-31
|
0.25
|
1992-10-01
|
1992-06-02
|
0.23
|
1992-07-01
|
1992-03-02
|
0.69
|
1992-04-01
|
1991-12-02
|
0.63
|
1992-01-02
|
1991-08-29
|
0.63
|
1991-10-01
|
1991-06-02
|
0.56
|
1991-06-30
|
1991-03-04
|
0.56
|
1991-04-01
|
1990-12-03
|
0.56
|
1991-01-02
|
1990-08-27
|
0.56
|
1990-10-01
|
1990-05-28
|
0.45
|
1990-07-01
|
1990-03-05
|
0.45
|
1990-04-02
|
1989-12-04
|
0.45
|
1990-01-02
|
1989-08-28
|
0.45
|
1989-10-02
|
1989-05-29
|
0.41
|
1989-07-04
|
1989-03-02
|
0.41
|
1989-04-03
|
1988-11-29
|
0.37
|
1989-01-03
|
1988-08-28
|
0.37
|
1988-10-03
|
1988-06-02
|
0.32
|
1988-07-04
|
1988-02-29
|
0.96
|
1988-04-04
|
1987-12-01
|
0.80
|
1988-01-04
|
1987-08-27
|
0.80
|
1987-10-01
|
1987-06-01
|
0.55
|
1987-06-30
|
1987-03-02
|
0.55
|
1987-04-01
|
1986-12-02
|
0.55
|
1987-01-02
|
1986-09-01
|
0.55
|
1986-10-01
|
1986-06-02
|
0.45
|
1986-06-30
|
1986-02-27
|
0.90
|
1986-04-01
|
1985-12-03
|
0.90
|
1986-01-02
|
1985-08-30
|
0.80
|
1985-10-01
|
1985-06-03
|
0.80
|
1985-07-01
|
1985-02-28
|
0.80
|
1985-04-01
|
1984-12-03
|
0.80
|
1985-01-02
|
1984-08-31
|
0.75
|
1984-10-01
|
1984-05-29
|
0.75
|
1984-07-02
|
1984-03-01
|
0.75
|
1984-04-02
|
1983-11-29
|
0.75
|
1984-01-02
|
1983-08-29
|
0.70
|
1983-09-30
|
1983-05-31
|
0.70
|
1983-06-30
|
1983-02-28
|
0.70
|
1983-04-01
|
1982-11-30
|
0.70
|
1983-01-03
|
1982-08-30
|
0.70
|
1982-10-01
|
1982-06-01
|
0.70
|
1982-07-01
|
1982-03-01
|
0.70
|
1982-04-01
|
1981-12-01
|
0.70
|
1982-01-04
|
1981-08-31
|
0.65
|
1981-10-01
|
1981-06-01
|
0.65
|
1981-07-01
|
1981-03-02
|
0.65
|
1981-04-01
|
1980-12-02
|
0.65
|
1981-01-02
|
1980-08-29
|
0.57
|
1980-10-01
|
1980-06-02
|
0.57
|
1980-07-01
|
1980-02-27
|
0.57
|
1980-03-31
|
1979-12-02
|
0.57
|
1980-01-01
|
1979-08-31
|
0.47
|
1979-10-01
|
1979-05-25
|
0.47
|
1979-07-02
|
1979-02-28
|
0.47
|
1979-04-01
|
1978-12-03
|
0.47
|
1979-01-01
|
1978-08-27
|
0.43
|
1978-10-01
|
1978-05-25
|
0.43
|
1978-06-30
|
1978-03-01
|
0.43
|
1978-03-31
|
1977-11-27
|
0.43
|
1978-01-01
|
1977-08-28
|
0.38
|
1977-09-30
|
1977-05-30
|
0.38
|
1977-06-30
|
1977-02-28
|
0.38
|
1977-03-31
|
